Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice
about
Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activityPregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoidNon-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficitsP2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophyLong-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophyMuscular response to the first three months of deflazacort treatment in boys with Duchenne muscular dystrophyPharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsEffect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.Satellite Cells in Muscular Dystrophy - Lost in Polarity.Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.Construction of a lentiviral vector containing shRNA targeting ADAM17 and its role in attenuating endotoxemia in mice.Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice.In vivo neutralization of IL-6 receptors ameliorates gastrointestinal dysfunction in dystrophin-deficient mdx mice.RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.
P2860
Q26782111-4E51CAD9-EB2F-41D1-BE52-83FCFA190FBBQ28544401-7B5BA8BE-D76F-4CAE-B013-C111CF81CD52Q28544896-9C862DD7-4166-41E0-A0E6-29BCBD383F50Q28550201-1B68E827-86E4-4903-97FE-12E5592FC605Q33649312-69C65513-09FA-434B-B511-33AF9F2BA427Q33856905-18B70D53-2AA2-4D1F-9F64-F81841673744Q34152280-889DCA00-472D-4E2F-9C80-F52ED4EC4CD3Q36026239-49AAF96E-F37E-4651-83E3-0690A8F487DEQ36948468-CAE157CC-46C8-4426-864E-F3E80E9679CBQ38888495-7405A9FE-6AE7-46E6-96C9-33B2B4A23877Q40076473-6C27A52D-0A62-41DF-8ABC-30F5B747B450Q41045084-B02CCEE8-7D0B-4AF0-9D2E-C90BF9679487Q43345556-54900AD7-23BF-43A6-934C-2538D0D969B0Q50977301-1C61D9B6-4AEE-4406-88DD-E28BCCB18C3D
P2860
Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Selective modulation through t ...... s muscle pathology in mdx mice
@ast
Selective modulation through t ...... s muscle pathology in mdx mice
@en
type
label
Selective modulation through t ...... s muscle pathology in mdx mice
@ast
Selective modulation through t ...... s muscle pathology in mdx mice
@en
prefLabel
Selective modulation through t ...... s muscle pathology in mdx mice
@ast
Selective modulation through t ...... s muscle pathology in mdx mice
@en
P2093
P2860
P50
P356
P1476
Selective modulation through t ...... s muscle pathology in mdx mice
@en
P2093
Guy Haegeman
Jack H Van Der Meulen
James L Quinn
Kathleen S Tatem
Mark Harris
P2860
P304
P356
10.1002/PATH.4231
P50
P577
2013-10-01T00:00:00Z